Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New ... ( Test aiding diagnosis of mental retar...)

Quest Diagnostics ClariSure(TM) Postnatal Molecular Test Receives Clinical Laboratory Approval from New York State

Date:3/17/2009

Test aiding diagnosis of mental retardation, birth defects, and autism spectrum and developmental disorders now approved for use on patients in New York

MADISON, N.J., March 17 /PRNewswire-FirstCall/ -- Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic testing, information and services, today announced that its ClariSure(TM) microarray-based comparative genomic hybridization (aCGH) postnatal test is now available for testing on patients in the state of New York. With licensure by the State Department of Health Clinical Laboratory Evaluation Program, Quest Diagnostics operates one of only three laboratories in the U.S. approved to perform aCGH testing on postnatal samples collected on patients in New York. The state has approved the use of the ClariSure aCGH postnatal test as an aid in detecting copy-number chromosomal abnormalities implicated in dozens of medical conditions, including mental retardation, birth defects, and autism spectrum and developmental disorders, which conventional laboratory tests may fail to detect.

"With approval by New York State, our advanced ClariSure test has demonstrated that it fulfills test validation requirements widely regarded as among the most rigorous in the lab industry," said Charles (Buck) Strom, M.D., Ph.D., medical director of the genetic testing center of Quest Diagnostics Nichols Institute, the esoteric testing laboratory and research and development center of Quest Diagnostics. "Since its launch in mid-2007, physicians outside of New York have used our ClariSure test to identify the genetic etiology of congenital anomalies, autism and other disorders for dozens of patients whose conditions had eluded prior diagnostic efforts. We look forward to providing broader access to our ClariSure test, so that more parents have the diagnostic insights they need
'/>"/>

SOURCE Quest Diagnostics Incorporated
Copyright©2009 PR Newswire.
All rights reserved

2

GOOD

Page: 1 2 3 4
Related medicine technology :

1. ImQuest Submits Investigational New Product Application to the Food and Drug Administration to Initiate HIV Therapeutic Clinical Trials with IQP-0410
2. Vermillion Renews Strategic Alliance Agreement With Quest Diagnostics, Inc.
3. Cephalon Receives Complete Response Letter Regarding Request for Expanded FENTORA Label for Non-Cancer Breakthrough Pain
4. Alpharma Announces Positive Results From Pivotal Phase III Efficacy Trial on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) Capsules at the American Academy of Pain Management Annual Clinical Meeting
5. Previous Claims of siRNA Therapeutic Effects Called into Question by Report in Human Gene Therapy
6. ImQuest Receives Two Year Phase 2 SBIR Grant to Develop Pyrimidinedione Product as an Anti-HIV Topical Microbicide
7. Ion Mobility Diagnostic Test from Quest Diagnostics is First to Provide Direct Physical Measurement of Lipoprotein Particles, Cardiovascular Disease Indicators, Study Finds
8. Alpharma Presents Data Addressing Abuse Liability Features, Safety and Efficacy on ALO-01 (EMBEDA(TM)) (morphine sulfate extended-release with sequestered naltrexone hydrochloride) at the American Pain Society Annual Scientific Session
9. Colorado Cancer Research Program Will Host Golf Event to Drive the Message that Clinical Trials Play a Vital Role in the Quest to Find a Cure for Cancer
10. FDA Grants NeoVistas Request to Expand CABERNET Trial to 30 Sites in the U.S.
11. ImQuest Scientists Present Important HIV Microbicide Development Results at Microbicides 2008 in Delhi, India

Post Your Comments:

(Date:5/20/2013)... Quebec , May 20, 2013 Valeant Pharmaceuticals International, ... members of its senior management team will make a presentation ... on Tuesday, June 11, 2013 at 9:20 a.m. PT. The ... Los Angeles, CA. A live ... on the company,s Web site at www.valeant.com . Click ...

(Date:5/20/2013)... BATESVILLE, Ind. , May 20, 2013 Hill-Rom ... to listen to a management presentation at the 38 ... Boston on May 30, 2013, ... ) You are invited to listen ... http://ir.hill-rom.com/events.cfm or access it directly at ...

(Date:5/20/2013)... ALISO VIEJO , Kalifornien, 20. Mai ... heute bekannt, dass das Unternehmen die CE-Kennzeichnung ... Implantate zur Embolisation von Aneurysmen erhalten hat. ... in Europa bereits mit der kontrollierten Einführung ... Profil bietet die SL-Produktfamilie auch ein verbessertes ...

Breaking Medicine Technology:Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 2 Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt 3

[0] Valeant Pharmaceuticals To Present At 34th Annual Goldman Sachs Global Healthcare Conference [0] Hill-Rom to Participate in the 38th Annual Deutsche Bank Health Care Conference [0] Sequent Medical, Inc. bringt neue SL-Produktfamilie seiner WEB Geräte zur Embolisation von Aneurysmen auf den Markt

... Ontario, July 18, 2011 CardioGenics Holdings Inc. (CGNH.OB) ... available for on-demand viewing at the RetailInvestorConferences website. ... will be available 24/7 for 90 days. Investors may ... the next three weeks. About CardioGenics ...

... July 18, 2011 Coronado Biosciences, Inc. (the "Company"), ... immunotherapy agents for the treatment of autoimmune diseases and ... on Form 10 with the Securities and Exchange Commission ... the purpose of becoming a reporting company. The filing ...

Cached Medicine Technology:CardioGenics Holdings Inc. Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com 2 Coronado Biosciences Files to Become a Public Reporting Company 2

CardioGenics Holdings Inc. Presentation Now Available for On-Demand Viewing at RetailInvestorConferences.com Coronado Biosciences Files to Become a Public Reporting Company

(Date:5/21/2013)... According to the Center for Disease Control and Prevention (CDC), ... Over 800,000 of these bites require medical attention, half of ... aware of the danger that dog bites pose to their ... may sustain more serious injuries than an adult. For ... of 5 and 9 are at the greatest risk of ...

(Date:5/20/2013)... USA Book News announced Monday that "The ... won the top honor in its 2013 International Book ... multitude of international titles published from 2011-2013, "The Infinity ... both mainstream and new age audiences looking to improve ... , “The Infinity Zone” is a phenomenon ...

(Date:5/20/2013)... This week has been dedicated as National Dog Bite Prevention ... an awareness campaign designated to help prevent dog bite injuries ... properly train their pets, and educate children on how to ... at Buckfire & Buckfire, P.C. represent victims of dog bites ... law firm is a large advocate of this week as ...

(Date:5/20/2013)... Minneapolis, MN (PRWEB) May 20, 2013 When ... right bed is only part of the process. Much of ... over the internet involves not knowing what to expect. ... expert advice consumers can use to ensure their purchase proves ... When You Buy a Mattress Online ”, readers find helpful ...

(Date:5/20/2013)... (PRWEB) May 20, 2013 The new ... lives and health of all Americans. However, not all ... immediate impact as some might take up to 2014 ... Human Services (HHS), some states are currently moving forward ... Insurance Marketplaces, such as: Iowa, Michigan, New Hampshire, and ...

Breaking Medicine News(10 mins):Health News:Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries 2 Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 2 Health News:Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards 3 Health News:Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week 2 Health News:See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online 2 Health News:Review of Health Bill Impact in 2014 2 Health News:Review of Health Bill Impact in 2014 3

[0] Personal Injury Law Firm Announces New Informational Graphic Regarding Dog Bite Injuries [0] Mystic Ink Publishing's "The Infinity Zone" Wins Top Honor - International Book Awards [0] Buckfire & Buckfire, P.C. Dog Bite Lawyers in Michigan Discuss National Dog Bite Prevention Week [0] See What to Expect When You Buy a Mattress Online With Latest Guide From Best Mattress Online [0] Review of Health Bill Impact in 2014

... ... launches SafeConsole 4.0, the web management software for SafeStick, the secure USB flash drive. ... administrators through a series of new features and range of licensing options. , ... Washington, DC (PRWEB) December ...

... , , ... a new market research report is available in ... Industry in the U.S. and its International Trade ... , The newly published In-Vitro Diagnostic Substance Manufacturing ...

... , , , ... a new market research report is available in ... Autoimmune Diseases Therapeutics - Market Forecasts to 2015, ... , http://www.reportlinker.com/p0168100/The-Future-of-Autoimmune-Diseases-Therapeutics---Market-Forecasts-to-2015-Competitive-Benchmarking-Product-Pipeline-and-Deals-Analysis.html , Summary ...

... , SANTA CLARA, Calif., Dec. 15 ... into Santa Clara County for the first time since ... Administrators will be assuming responsibilities and provider contracts previously ... , Operating on a locally based healthcare philosophy, Coastal ...

... is widely thought to be the major form of the ... Research Program (MHRP) researchers, however, have demonstrated that essentially all ... of red blood cells isolated from each of 30 normal ... PLoS ONE , and can be accessed here. ...

... 2009Do good-looking people really benefit from their looks, and in ... Georgia and the University of Kansas found that yes; attractive ... an increased sense of psychological well-being. This seems like common ... each year trying to become more attractive. However, the study, ...

BlockMaster Launches SafeConsole 4.0 To Enhance Usability and Security of USB Devices Reportlinker Adds In-Vitro Diagnostic Substance Manufacturing Industry in the U.S. and its International Trade [Q4 2009 Edition]Reportlinker Adds The Future of Autoimmune Diseases Therapeutics - Market Forecasts to 2015, Competitive Benchmarking, Product Pipeline and Deals Analysis Coastal Healthcare Administrators Expands Provider Network to Santa Clara County New insight into selective binding properties of infectious HIV The importance of attractiveness depends on where you live

... flexible lighting products. The first is available ... sizes 5", 10", and 15" (refers to ... These lights are for use in procedures ... second group of flexible lights is our ...

... Aaron manufactures two groups of flexible lighting ... and non-sterile in three different sizes 5", ... shaft portion of the light). These lights ... light is needed., ,The second group ...

... Aaron manufactures two groups of flexible ... sterile and non-sterile in three different sizes ... flexible shaft portion of the light). These ... additional light is needed., ,The second ...

... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...

Medicine Products:

Surch-Lite™ Flexible Light - 10" Sterile Surch-Lite™ Flexible Light - 5" Sterile Lighted Pediatric Stylet - Non-Sterile Lighted Orotracheal Stylet - Sterile